Last updated on November 2018

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis


Brief description of study

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching). 

All enrolled subjects will receive oral medication to be taken daily for 8 weeks. There are 9 in-office visits throughout the study and can include a physical exam, blood draws, urine sampling, assessments by qualified professionals and other assessments which will be reviewed in detail at your screening visit. All services are provided at no cost.

Clinical Study Identifier: TX205367

Find a site near you

Start Over

Sadick Research Group

911 Park Avenue, Ste. 1A New York, NY United States
  Connect »